Vanda Pharmaceuticals
VNDA
#8792
Rank
A$0.32 B
Marketcap
A$5.33
Share price
-3.68%
Change (1 day)
-32.69%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2026 (TTM): -A$0.26 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are A$0.22 Billion. In 2025 the company made an earning of -A$0.23 Billion a decrease over its 2024 earnings that were of -A$61.32 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.26 Billion13.61%
2025 -A$0.23 Billion271.79%
2024 -A$61.32 Million191.43%
2023 -A$21.04 Million-320.45%
2022 A$9.54 M-84.99%
2021 A$63.58 M54.8%
2020 A$41.07 M19.42%
2019 A$34.39 M4.93%
2018 A$32.78 M-228.6%
2017 -A$25.49 Million-8.98%
2016 -A$28.01 Million-53.79%
2015 -A$60.6 Million-30.18%
2014 -A$86.8 Million173.08%
2013 -A$31.79 Million-25.33%
2012 -A$42.57 Million163.61%
2011 -A$16.15 Million-221.15%
2010 A$13.32 M-124.53%
2009 -A$54.34 Million-29.44%
2008 -A$77.01 Million-36.2%
2007 -A$0.13 Billion21.81%
2006 -A$99.09 Million170.55%
2005 -A$36.63 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$28.23 B-10,622.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$19.06 B-7,206.52%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$10.50 B-4,016.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$52.43 B-19,643.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$10.13 B-3,878.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$17.08 B-6,469.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-A$4.23 Million-98.42%๐Ÿ‡บ๐Ÿ‡ธ USA